A landmark paper for the NK cell field, great work, congratulations team!

Huge congratulations MalmbergLab and co-authors on this groundbreaking paper! A significant advance for the field #NK #CancerResearch #immunotherapy

Taken together, in this study in Cell Stem Cell, we demonstrate that modulating the immune synapse can be a promising strategy to avert rejection by the host and hopefully further unlock 🔓 the potential of next-generation allogeneic #Immunotherapy against #cancer

Malmberg and colleagues provide a single-cell transcriptional reference map of healthy human NK cells and use this profile of tumor infiltrating NK cells. Read it here: rdcu.be/dM6V4 nature.com/articles/s4159…

Comprehensive thread highlighting our most recent work now out in Cell Stem Cell describing a novel approach to increase persistence of allogeneic cell therapy products. Work led by amazing Quirin Hammer and @KarloPerica. Precision Immunotherapy Alliance, Oslounivsykehus UiO - Det medisinske fakultet Karolinska Institutet

Understanding NK cell heterogeneity dlvr.it/T9WTGk

Thanks for this nice and thoughtful commentary of our work. We hope this approach will make a difference in the allogeneic cell therapy space for both T and NK cell based therapies.

Exciting work by Horowitz Lab @Icahn School of Medicine Mount Sinai and team! Congrats to all. HLA-E and NKG2A Mediate Resistance to M. bovis BCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer biorxiv.org/content/10.110…

GPR56 functions as an upstream checkpoint for migration of highly differentiated NK cells The Journal of Immunology MalmbergLab Daniel Palacios (he/him) doi.org/10.4049/jimmun…

Congrats Daniel Palacios (he/him). Understanding the migratory behavior of NK cells is critical to overcome one of the major bottlenecks in the field: to make NK cells home to solid tumors. The inhibitory GPR56 axis is one piece of the puzzle.

Very important and much needed funding to establish ATMP Norway, a multi-nodal national infrastructure for cell and gene therapy. Building on investments in GMP laboratories at Oslounivsykehus and Haukeland University Hospital and a partnership with UiO - Det medisinske fakultet.

Working with a great team including Nathan Singh & Stephan Mielke to organize Keystone Symposia Immune #CellTherapy: Advances in #Cancer and #AutoimmuneDisease Please join us to explore emerging research in Banff, March 16-19, 2025  | Fairmont Banff Springs, Banff, AB, Canada

Online Now: Targeting HLA-E-overexpressing cancers with a NKG2A/C switch receptor dlvr.it/TFV5VC

A cell intrinsic NKG2A/C switch receptor to overcome the critical HLA-E checkpoint. Fun collaboration with the Michel Sadelain lab. Michelle Sætersmoen, Ivan Kotchetkov, Dr. Lamberto Torralba-Raga Precision Immunotherapy Alliance UiO - Det medisinske fakultet Oslounivsykehus Center for Infectious Medicine

We have an open 2-year postdoc position focusing on computational approaches to identify antigen-specific immune receptors from adaptive immune repertoire data. Application deadline: Nov 6. jobbnorge.no/en/available-j…

Wow, congrats @PN0rmski. Beautiful work!

Incredibly impressing ongoing work in the UK NK community. Thanks for the invitation Malcolm Sim. Looking forward to discussing more NK and KIR work in the coming days and to the yearly double 🎾 with Francesco Colucci

Great work, congrats. This is where we have to go.